Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Many religious people with terminal cancer put more faith in the hope for a miracle than in the medical information they receive.
Annual screenings cut mortality rates by 24% in men and 33% in women.
This finding from a recent study applies to those who do not have cirrhosis when they are treated for the virus.
A new classification system may more accurately reflect liver-related death trends in the United States.
In the era of highly effective treatments for both viruses, HIV doesn’t speed the advancement of cirrhosis.
South Korean researchers found no difference in the rates of liver cancer, liver transplant or death based on the treatment used.
Allison Ruddick is the creator of the Keeping Cancer Classy blog.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
An analysis conducted in Taiwan analyzed health outcomes over more than a decade.
This held true regardless of whether statins were taken before or after the cancer diagnosis.
Researchers reached this conclusion after reviewing data on more than 30,000 people.
The drug is still associated with a lower liver cancer rate than Baraclude.
Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.
Mental health care before cancer treatment is associated with higher death rates for those with kidney, prostate or bladder cancer.
To improve overall health and longevity, replace sweetened beverages with water and other sugarless drinks.
Kadcyla reduces the risk of breast cancer recurring and spreading after surgery.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.